Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance

The Role of Metallothionein in Oxidative Stress

(2013) Branislav Ruttkay-Nedecky et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Human Metallothionein Expression under Normal and Pathological Conditions: Mechanisms of Gene Regulation Based on In silico Promoter Analysis

(2012) Debby Laukens et al.   CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION

From Amino Acids to Proteins as Targets for Metal-based Drugs

(2012) Ondrej Zitka et al.   CURRENT DRUG METABOLISM

Metallothioneins and zinc in cancer diagnosis and therapy

(2012) Sona Krizkova et al.   DRUG METABOLISM REVIEWS

P53 and its molecular basis to chemoresistance in breast cancer

(2012) Stian Knappskog et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Insight to Physiology and Pathology of Zinc(II) Ions and Their Actions in Breast and Prostate Carcinoma

(2011) J. Gumulec et al.   CURRENT MEDICINAL CHEMISTRY

CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis

(2011) Olivia Fromigue et al.   JOURNAL OF BONE AND MINERAL RESEARCH

A Review of Metallothionein Isoforms and their Role in Pathophysiology

(2011) N Thirumoorthy et al.   World Journal of Surgical Oncology

Role of metallothionein in cadmium traffic and toxicity in kidneys and other mammalian organs

(2010) Ivan Sabolić et al.   BIOMETALS

Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone

(2010) L Endo-Munoz et al.   BRITISH JOURNAL OF CANCER

Interaction of Tumor Suppressor p53 with DNA and Proteins

(2010) Jianxiu Wang et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Role of zinc in cellular zinc trafficking and mineralization in a murine osteoblast-like cell line

(2010) Masashi Nagata et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Zinc may increase bone formation through stimulating cell proliferation, alkaline phosphatase activity and collagen synthesis in osteoblastic MC3T3-E1 cells

(2010) Hyun-Ju Seo et al.   Nutrition Research and Practice

Studies of interaction of tumor suppressor p53 with apo-MT using surface plasmon resonance

(2009) Ning Xia et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Profiling of Chemonaive Osteosarcoma and Paired-Normal Cells Identifies EBF2 as a Mediator of Osteoprotegerin Inhibition to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis

(2009) A. Patino-Garcia et al.   CLINICAL CANCER RESEARCH

Metallothioneins and Platinum(II) Anti-Tumor Compounds

(2009) Markus Knipp   CURRENT MEDICINAL CHEMISTRY

Metallothioneins and Cancer

(2009) Tomas Eckschlager et al.   CURRENT PROTEIN & PEPTIDE SCIENCE

Role of nutritional zinc in the prevention of osteoporosis

(2009) Masayoshi Yamaguchi   MOLECULAR AND CELLULAR BIOCHEMISTRY

FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/β-catenin signaling-dependent Runx2 expression

(2008) Zahia Hamidouche et al.   FASEB JOURNAL

Blockade of the RhoA-JNK-c-Jun-MMP2 Cascade by Atorvastatin Reduces Osteosarcoma Cell Invasion

(2008) Olivia Fromigué et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Over-expression of metallothionein predicts chemoresistance in breast cancer

(2008) Xinli Yap et al.   JOURNAL OF PATHOLOGY

Statin-Induced Inhibition of 3-Hydroxy-3-Methyl Glutaryl Coenzyme A Reductase Sensitizes Human Osteosarcoma Cells to Anticancer Drugs

(2008) O. Fromigue et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Differential expression of metallothioneins (MTs) 1, 2, and 3 in response to zinc treatment in human prostate normal and malignant cells and tissues

(2008) Hua Wei et al.   Molecular Cancer

Modulation of Genes Involved in Zinc Homeostasis in Old Low-Grade Atherosclerotic Patients Under Effects of HMG-CoA Reductase Inhibitors

(2008) Laura Costarelli et al.   REJUVENATION RESEARCH